at Investor's Business Daily (Wed, 3:35PM)
Amgen (AMGN +1.3%) ticks up after its Q3 beat on bottom line estimates late yesterday. Net earnings more than doubled as newer products boosted revenue growth and its bottom line was aided by an absence of litigation-related charges. The company also guided FY12 revenue higher, now expecting to earn around $17.2B - $17.3B and its EPS to $6.50 - $6.60. The Street view was for $17.06 bln and and EPS number of $6.33.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Wed, 10:00AM)
at Investor's Business Daily (Tue, 6:10PM)
at Zacks.com (Fri, 6:25PM)
at Zacks.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs